Prostaglandin analogue
US4562207A · kind A · utility
10Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 1984 |
| Grant date | Dec 31, 1985 |
| Priority date | — |
| Expiry date | Mar 8, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08B37/0015
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A novel prostaglandin analogue of the formula: ##STR1## [wherein the symbol represents .beta.-configuration, the dotted line ---------- represents .alpha.-configuration, and the double bond between C.sub.13 -C.sub.14 represents transconfiguration] and cyclodextrin clathrates thereof, and non-toxic salts thereof are useful for the treatment and/or prevention of diseases induced by platelet aggregation, such as thrombosis, or induced by cytodamage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.